BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28295365)

  • 21. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.
    Padul V; Epari S; Moiyadi A; Shetty P; Shirsat NV
    Genes Chromosomes Cancer; 2015 Dec; 54(12):725-33. PubMed ID: 26357005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Dynamics of Signal-Dependent Transcriptional Repression by Capicua.
    Keenan SE; Blythe SA; Marmion RA; Djabrayan NJ; Wieschaus EF; Shvartsman SY
    Dev Cell; 2020 Mar; 52(6):794-801.e4. PubMed ID: 32142631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide identification of MAPK, MAPKK, and MAPKKK gene families and transcriptional profiling analysis during development and stress response in cucumber.
    Wang J; Pan C; Wang Y; Ye L; Wu J; Chen L; Zou T; Lu G
    BMC Genomics; 2015 May; 16(1):386. PubMed ID: 25976104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade.
    Song MS; Park YK; Lee JH; Park K
    Cancer Res; 2001 Nov; 61(22):8322-30. PubMed ID: 11719466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation-induced substrate engagement in ERK signaling.
    Paul S; Yang L; Mattingly H; Goyal Y; Shvartsman SY; Veraksa A
    Mol Biol Cell; 2020 Feb; 31(4):235-243. PubMed ID: 31913744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.
    van Dam PA; van Dam PJ; Rolfo C; Giallombardo M; van Berckelaer C; Trinh XB; Altintas S; Huizing M; Papadimitriou K; Tjalma WA; van Laere S
    Oncotarget; 2016 Jan; 7(3):2780-95. PubMed ID: 26701206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.
    Wang B; Krall EB; Aguirre AJ; Kim M; Widlund HR; Doshi MB; Sicinska E; Sulahian R; Goodale A; Cowley GS; Piccioni F; Doench JG; Root DE; Hahn WC
    Cell Rep; 2017 Feb; 18(6):1543-1557. PubMed ID: 28178529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas.
    Lee CJ; Chan WI; Scotting PJ
    J Neurooncol; 2005 Jun; 73(2):101-8. PubMed ID: 15981098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
    Choi N; Park J; Lee JS; Yoe J; Park GY; Kim E; Jeon H; Cho YM; Roh TY; Lee Y
    Oncotarget; 2015 Sep; 6(27):23533-47. PubMed ID: 26124181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA ENST00462717 suppresses the proliferation, survival, and migration by inhibiting MDM2/MAPK pathway in glioma.
    Wang A; Meng M; Zhao X; Kong L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):513-521. PubMed ID: 28189682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of genomic targets of transcription factor AEBP1 and its role in survival of glioma cells.
    Ladha J; Sinha S; Bhat V; Donakonda S; Rao SM
    Mol Cancer Res; 2012 Aug; 10(8):1039-51. PubMed ID: 22723309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer.
    Bizama C; Benavente F; Salvatierra E; Gutiérrez-Moraga A; Espinoza JA; Fernández EA; Roa I; Mazzolini G; Sagredo EA; Gidekel M; Podhajcer OL
    Int J Cancer; 2014 Feb; 134(4):755-64. PubMed ID: 23907728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo.
    Zhang J; Zhang QY; Fu YC; Wang T; Zhang J; Xu P; Zhou X; Pu PY; Kang CS
    Technol Cancer Res Treat; 2009 Dec; 8(6):467-78. PubMed ID: 19925030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells.
    Kruczyk M; Przanowski P; Dabrowski M; Swiatek-Machado K; Mieczkowski J; Wallerman O; Ronowicz A; Piotrowski A; Wadelius C; Kaminska B; Komorowski J
    Biochim Biophys Acta; 2014 Nov; 1839(11):1341-50. PubMed ID: 25111868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
    Mondal B; Patil V; Shwetha SD; Sravani K; Hegde AS; Arivazhagan A; Santosh V; Kanduri M; Somasundaram K
    Oncogene; 2017 Jan; 36(1):71-83. PubMed ID: 27212030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the uPA gene in various grades of human glioma cells.
    Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS
    Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome and coexpression network analysis of the human glioma cell line Hs683 exposed to candoxin.
    Jiang YX; Ma Y; Cheng Y
    J Int Med Res; 2012; 40(3):887-98. PubMed ID: 22906261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.